Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hims & Hers Health (HIMS)
NYSE:HIMS
Holding HIMS?
Track your performance easily
HIMS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.65 - $25.74
Previous Close$16.31
Volume5.68M
Average Volume (3M)9.02M
Market Cap
$3.53B
Enterprise Value$3.31B
Total Cash (Recent Filing)$227.29M
Total Debt (Recent Filing)$11.47M
Price to Earnings (P/E)218.0
Beta2.21
Next Earnings
Nov 04, 2024EPS Estimate
$0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.07
Shares Outstanding217,079,873
10 Day Avg. Volume6,531,626
30 Day Avg. Volume9,015,469
Standard Deviation0.20
R-Squared0.08
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)9.77
Price to Sales (P/S)3.28
Price to Cash Flow (P/CF)16.30
P/FCF Ratio18.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.11
Enterprise Value/Gross Profit4.64
Enterprise Value/Ebitda27.65
Forecast
1Y Price Target
$21.09Price Target Upside24.72% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
Hims & Hers Health News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceEven without contribution from GLP-1, HIMS is growing 40%+ at over $1 billion in revenue and boasts multiple levers for growth and margin expansion.
Product OfferingHIMS is a leading brand dedicated to providing accessible and affordable healthcare solutions for sexual health, dermatology, mental health, and weight loss through its digital platform.
Sales GrowthObserved sales growth accelerated for the fifth consecutive month with 79% year-over-year growth in August.
Bears Say
Financial PerformanceOrder growth decelerated 40bps q/q and missed Street expectations which can provide some insight into core vs. GLP-1 growth.
Market VolatilityThe headline risks of shortages ending will still create share volatility given the uncertainty it creates on consensus forecasts.
Regulatory IssuesThe U.S. Federal Trade Commission (FTC) began an inquiry into Hims & Hers related to billing issues concerning cancelling subscriptions and obtaining refunds.
---
Ownership Overview
37.10% Insiders
16.63% Mutual Funds
27.66% Other Institutional Investors
18.61% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
The estimated number of people who visited one or more of the websites owned by Hims & Hers Health
Desktop Users
Mobile Users
HIMS FAQ
What was Hims & Hers Health’s price range in the past 12 months?
Hims & Hers Health lowest stock price was $5.65 and its highest was $25.74 in the past 12 months.
What is Hims & Hers Health’s market cap?
Currently, no data Available
When is Hims & Hers Health’s upcoming earnings report date?
Hims & Hers Health’s upcoming earnings report date is Nov 04, 2024 which is in 46 days.
How were Hims & Hers Health’s earnings last quarter?
Hims & Hers Health released its earnings results on Aug 05, 2024. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.045 by $0.015.
Is Hims & Hers Health overvalued?
According to Wall Street analysts Hims & Hers Health’s price is currently Undervalued.
Does Hims & Hers Health pay dividends?
Hims & Hers Health does not currently pay dividends.
What is Hims & Hers Health’s EPS estimate?
Hims & Hers Health’s EPS estimate is $0.11.
How many shares outstanding does Hims & Hers Health have?
Hims & Hers Health has 208,068,620 shares outstanding.
What happened to Hims & Hers Health’s price movement after its last earnings report?
Hims & Hers Health reported an EPS of $0.06 in its last earnings report, beating expectations of $0.045. Following the earnings report the stock price went down -5.381%.
Which hedge fund is a major shareholder of Hims & Hers Health?
Among the largest hedge funds holding Hims & Hers Health’s share is Royce & Associates LLC. It holds Hims & Hers Health’s shares valued at 6M.
---
Hims & Hers Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$21.09 (24.72% Upside)
$21.09 (24.72% Upside)
Blogger Sentiment
Bullish
HIMS Sentiment 86%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 3.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $106.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 0.7%
Last 30 Days ▲ 1.6%
Last 30 Days ▲ 1.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
157.25%
12-Months-Change
Fundamentals
Return on Equity
5.31%
Trailing 12-Months
Asset Growth
23.24%
Trailing 12-Months
Company Description
Hims & Hers Health
Oaktree Acquisition Corp. is an emerging growth company, which engages in the provision of merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded by Patrick McCaney, Alexander Taubman and Mathew Pendo in 2019 and is headquartered in Los Angeles, CA.
---
HIMS Earnings Call
Q2 2024
0:00 / 0:00
---
HIMS Revenue Breakdown
96.60% Online
3.40% Wholesale
---
HIMS Stock 12 Month Forecast
Average Price Target
$21.09
▲(24.72% Upside)
Technical Analysis
Best Analysts Covering HIMS
1 Year
1 Year Success Rate
7/7 ratings generated profit
1 Year Average Return
+75.34%
reiterated a buy rating 7 months ago
Copying Jack Wallace's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +75.34% per trade.
---